Only the facts
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Delusional
Facts
If the company declares Chapter 7, the company is dead, and so are your shares.
Just read the United States Bankruptcy Code
Cheers
Hilarious
IMNPQ It's over. I recommend you all pay close attention to United States Bankruptcy Court.
Chapter 7 = Total Liquidation
Your shares are Revoked and can't change.
Shareholders will not see any recovery or distribution of proceeds from sales of assets..
Shareholder value $0.00
CHEERS
Seriously
ESH ACQUISITION CORP
We intend to focus our search on businesses in the global entertainment, sports and hospitality sectors.
Have a wonderful evening.
Cheers
Letterpenny
You are delusional and in denial.
Lawsuits against Dr.Teper by the trustee and settlement made by the insurance company for millions for the benefit of the estate.
Discover paid in full and purchased Ceplene for under 200,000.00.+
You been here and have been posting positive statements and now you are down 100% .
Your shares are worthless.
Keep believing your share will have value that in itself is hilarious.
You are a fool in the United States Chapter 7 means total liquidation.
Your shares will always be worthless to continue to state otherwise is disingenuous.
Cheers
Letterpenny
You are a funny man Posted because someone wanted to know why shareholders didn't sued Immune Pharmaceuticals Inc.
Just posted facts.
Have a wonderful evening
Cheers
Here is why it's too late to sue Dr.Teper etc
ORDERED that any person or entity who has held, holds, or could hold or assert any claim, action, or cause of action of any kind, both known and unknown, against any of the Parties as defined in the Settlement Agreement, including but not limited to Discover, any directors or officers of the Debtors, the Trustee, or the Debtors or their bankruptcy estates, except governmental agencies, is permanently enjoined, restrained, and barred from filing, commencing, conducting, asserting, or continuing in any manner, directly, indirectly, or derivatively, any suit, action, claim, demand, or other proceeding (including, without limitation, any proceeding in any judicial, arbitral, administrative, or other forum) against any of the Parties, including but not limited to Discover, any directors or officers of the Debtors, the Trustee, or the Debtors or their bankruptcy estates, based upon, arising from, or attributable to the acts or omissions of the Former Director and Officer Defendants as defined in the Settlement Agreement in their capacity as directors or officers of the Debtors or in any way related to the Debtors or the Litigation Matters as defined in the Settlement Agreement, or against the Insurer in connection with the directors or officers of the Debtors, the Debtors, the 2018 Transaction as defined in Section 3.C of the Settlement Agreement, or the Litigation Matters as defined in the Settlement Agreement. Except as otherwise provided in the Settlement Agreement, this Order shall not, however, impact, impair, or affect any rights that an insured may have under the Policy as defined in the Settlement Agreement or
any other arrangement among an insured and the Insurer. For the avoidance of doubt, this Order does not release, impair, limit or otherwise affect any right, claim or cause of action that Discover may have against any third party individual or entity that is not a party to the Settlement Agreement and that is an insured under any insurance policy issued by the Insurer that is not the Policy.
Letterpenny
Your statement "Cytovia is now fully funded thanks to Isleworth"
That statement is totally false and is a deliberate act of deviating from the truth.
Cheers
PS FYI
The SPAC will cease all operations on August 29, and shareholders are expected to receive shortly thereafter $10.01 per share. As a result of the liquidation, Isleworth has also cancelled its special meeting of shareholders to extend its deadline that was previously scheduled for tomorrow, August 26.
Isleworth Healthcare Acquisition Corp Dissolved.
PENNY
Motions to convert to Chapter 7 for cause may be granted if the court examines the facts of the case and finds one or more of the following:
The debtor has no profitable core business around which to structure a reorganization.The debtor cannot or will not formulate a reasonable reorganization plan.
The US Bankruptcy Court gave an order granting the conversion of Chapter 11 reorganization case of Immune Pharmaceuticals, Inc. to liquidation under Chapter 7 on April 2, 2020
Further more Are you kidding me!
You turn away from listening to the truth and wander off into myths; in fact, you reject the truth.
Stock registration revoked.
Chapter 7= Total Liquidation
Stock will never trade again
On October 21, 2019, the Bankruptcy Court entered an order approving the Debtors’ sale of the Bert Assets to Alexion Pharma International Operations Unlimited Company (“Alexion”)
On October 28, 2020, the Bankruptcy Court entered an order approving the sale of Immune Pharmaceuticals Inc.’s etc interest in the Ceplene Assets to Discover Growth Fund, LLC
Immune pharmaceuticals of Nevada dissolved
Isleworth Healthcare Dissolved
Shares will never trade again.
Your statement "I can’t wait till next year when the SPAC / merger closes."
Impossible Isleworth Healthcare closed down .
Immune Pharmaceuticals and all its subsidiaries will be a empty shell with no officers or directors just liabilities.
You are delusional and narcissistic
You have 100% loss.
Cheers
Your statement :
What’s convenient is a user consistently claiming the company is done for with no explanation of why it’s received 16 extensions.
Just read the court filing it is all there.
Cheers
Letterpenny
Funny man
It wasn't addressed to you take your riches and your tax write-off and enjoy your life .
Keep on dreaming that you will be made richer by investing in Immune pharmaceuticals
He He
Cheers
Immune Pharmaceuticals shareholders doesn't have any vested interest in Cytovia Therapeutics or any of Dr. Teper's new companies to state otherwise is Hilarious.
Immune Pharmaceuticals of Nevada Dissolved.
Isleworth Dissolved
Fact: Immune Pharmaceuticals Chapter 7 which means total liquidation under the United States Bankruptcy Code.
After the trustee files a final report and the trustee is discharged from his position by the judge.
Immune pharmaceuticals will be a shell company with no officers or directors just liabilities.
No IPO will or anything else will ever benefit immune pharmaceuticals shareholders to state otherwise Hilarious
Shareholders Value ZERO
CHEERS
You should realized that Dr Teper could care less about Immune pharmaceuticals shareholders
Maybe this will help you understand how all the smoke and mirrors by immune and messages boards pump immune pharmaceuticals shares.
Early in the bankruptcy cases, Vector Therapeutics, Inc. (“Vector”), a company allegedly controlled by Teper, on the one hand, and Immune, on the other hand, entered into an Asset Purchase Agreement whereby Vector would purchase the Ceplene assets from Immune for the sum of $2.25 million and the assumption of certain liabilities. Am. Compl. (Adv. Pro. No. 21-01230 ECF 8) Exh. A ¶ 120. At a hearing on March 29, 2019, Vector informed this Court that it did not have the funds to close the purchase but that it would shortly. Id. ¶ 121.
(Never Happened)
On October 28, 2020, this Court ultimately approved the sale of the Ceplene assets and other assets of the Debtors’ estates for the sum of $190,000. Order (ECF 578).
Immune pharmaceuticals has no interest in Cytovia Therapeutics nor does Cytovia Therapeutics has any interest in Immune pharmaceuticals.
Shareholders value ZERO to state otherwise is disingenuous.
Cheers
ORDER PURSUANT TO SECTION 365(d)(1) OF THE BANKRUPTCY CODE EXTENDING THE DEADLINE TO ASSUME OR REJECT EXECUTORY CONTRACTS AND PERSONAL PROPERTY LEASES
The relief set forth on the following page, numbered two (2), is hereby ORDERED.
DATED: September 7, 2023
THIS MATTER having been opened to the Court by Jeffrey A. Lester, Chapter 7 Trustee (the “Trustee”) of the above-captioned estates, seeking, pursuant to Section 365(d)(1) of the Bankruptcy Code, an extension of the deadline to assume or reject executory contracts and personal property leases for ninety (90) days; due notice hereof having been given; a limited objection having been filed by Porzio Bromberg (the “Objecting Party”) seeking, among other things, a reduced extension time period to facilitate a potential case closure and distribution by yearend (the “Objection”); this Court having proposed to resolve the Objection by authorizing an interim distribution to Chapter 11 administrative claimants prior to yearend; and hearings having been held on August 8, 2023 and August 24, 2023 on the issues raised; upon consent of the Objecting Party and for good cause shown
IT IS ORDERED that:
1.
The deadline for the Trustee, pursuant to Section 365(d)(1), to assume or reject executory contracts and personal property leases be and it is hereby extended for ninety (90) days from the date of entry of this order.
2.
The Trustee be and hereby is authorized to make an interim distribution in an amount not to exceed $600,000 prior to yearend on behalf of allowed Chapter 11 administrative claims (the “Interim Distribution”) provided that the anticipated settlement payment from the Israeli Liquidator (the “Israeli Payment”) is received by the Trustee in sufficient time to enable him to make the Interim Distribution on or before December 31, 2023.
3.
Any distributions received by the Chapter 11 administrative claimants shall be subject to disgorgement if, after the Interim Distribution, the (i) reserve for estimated unpaid Chapter 7 administrative claims created by the Trustee and (ii) balance remaining of the Israeli Payment are insufficient to cover allowed Chapter 7 administrative claims.
1.
The deadline for the Trustee, pursuant to Section 365(d)(1), to assume or reject executory contracts and personal property leases be and it is hereby extended for ninety (90) days from the date of entry of this order.
2.
The Trustee be and hereby is authorized to make an interim distribution in an amount not to exceed $600,000 prior to yearend on behalf of allowed Chapter 11 administrative claims (the “Interim Distribution”) provided that the anticipated settlement payment from the Israeli Liquidator (the “Israeli Payment”) is received by the Trustee in sufficient time to enable him to make the Interim Distribution on or before December 31, 2023.
3.
Any distributions received by the Chapter 11 administrative claimants shall be subject to disgorgement if, after the Interim Distribution, the (i) reserve for estimated unpaid Chapter 7 administrative claims created by the Trustee and (ii) balance remaining of the Israeli Payment are insufficient to cover allowed Chapter 7 administrative claims.
4.
All parties-in-interest including the Trustee and the Objecting Party preserve all rights and remedies of any kind or nature other than those described herein.
The above is the completed order of the court.
****************
There will be no distribution for shareholders.
100 percent shareholders loss .
😭
Cheers
Letterpenny
No hate it's all about telling the truth
Facts are facts
Have a wonderful evening.
Cheers
Letterpenny
The following statement by you false.
"Adeel is still active with Immune. My shares are frozen and acquired"
According to the State of Nevada Immune Pharmaceuticals dissolved. Therefore it no longer exists as a legal entity.
You are either delusional or you are narcissistic.
Life is awesome
Cheers
Hilarious
Total Denial
Letterpenny you continue talking in circles very entertaining .
Waiting for your next delusional spin.
Chapter 7 = Total Liquidation.
Cuckoo Penny perfect name
Smile
Cheers
That's news to me as stated on many occasions I never shorted any stock.
I sold all my shares except for 1000 which I keep for legal reasons.
Dr Teper could care less about shareholders of Immune Pharmaceutical.
Dr Teper could have saved Immune Pharmaceuticals from being liquidated if he honor his commitment:
Maybe this will help you understand how the smoke and mirrors by immune and posting on messages boards pumped immune pharmaceuticals share and gave shareholders false hope.
Early in the bankruptcy cases, Vector Therapeutics, Inc. (“Vector”), a company allegedly controlled by Teper, on the one hand, and Immune, on the other hand, entered into an Asset Purchase Agreement whereby Vector would purchase the Ceplene assets from Immune for the sum of $2.25 million and the assumption of certain liabilities. Am. Compl. (Adv. Pro. No. 21-01230 ECF 8) Exh. A ¶ 120. At a hearing on March 29, 2019, Vector informed this Court that it did not have the funds to close the purchase but that it would shortly. Id. ¶ 121.
(Never Happened)
On October 28, 2020, this Court ultimately approved the sale of the Ceplene assets and other assets of the Debtors’ estates for the sum of $190,000. Order (ECF 578).
Many more examples just read the court records.
Shares worthless to state otherwise is disingenuous.
Beautiful in Vermont here for rest and relaxation.
Cheers
Letterpenny
DELUSIONAL
ALL FANTASY
YOU ARE IN DENIAL
IMMUNE PHARMACEUTICALS CHAPTER 7 =TOTAL LIQUIDATION
ISLEWORTH HEALTHCARE ACQUISITION CORP DISSOLVED.
IMMUNE PHARMACEUTICALS OF NEVADA DISSOLVED.
IMMUNE PHARMACEUTICALS SHARES WORTHLESS.
LIVE AND LEARN
CHECK WITH THE STATE OF NEVADA REGARDING IMMUNE PHARMACEUTICALS OF NEVADA OUT OF BUSINESS
READ CHAPTER 7 OF THE US BANKRUPTCY CODE.
You do make me laugh with all your DELUSIONAL thoughts
Smile
Life is awesome
Cheers
Letterpenny
Talking in circles again.
Cytovia inc is being liquidated
Case number: 2:19-bk-13896 - Cytovia, Inc. - New Jersey Bankruptcy Court
SPAC Isleworth Healthcare Dissolved
You are delusional and a pathological liar.
Learn to get your facts correct you lost 100% of your investment.
YOUR STATEMENT THAT
"Cytovia Therapeutics Inc. which merged with Isleworth Healthcare Acquisition" IS A FALSE NARRATIVE USED BY YOU TO MAKE YOU FEEL BETTER.
SAD THAT YOU NOW BELIEVE YOUR OWN LIES
Praying for my family and friends in KELOWNA.
Cheers
Letterpenny
Your statement is correct
"Cytovia Inc is a wholly owned subsidiary of Immune Pharmaceuticals. You are right. When Parent company owns a wholly owned sub the shareholders own the Sub. So when I owned 9 percent of Immune, I also own 9 percent of Cytovia.."
What you failed to mention Immune Pharmaceuticals and all its subsidiaries are being liquidated.
YOUR INVESTMENT IN IMMUNE PHARMACEUTICALS INC
WORTHLESS.
IN DENIAL OR JUST DELUSIONAL.
The fire in Kelowna is scary
Stay safe
Cheers
Thank You
My health fantastic
Immune pharmaceuticals of Nevada DISSOLVED
Cytovia Therapeutics and short for Cytovia Dr Teper
Cytovia Inc a subsidiary of Immune Pharmaceuticals Liquidating
Your statement
" I should know this cause I own a piece of it through my rights."
Really I guess you are delusional.
Meditation in September
Frankel v. Cytovia Therapeutics, Inc. Case settled
You are in Denial
Life is awesome
Be well
Cheers
Letterpenny
Poster presented at the meeting "Antibody Engineering & Therapeutics, 2021" for Cytovia Therapeutics Inc.
Also when Dr Teper talks about Cytovia he is doing that on behalf of Cytovia Therapeutics.
Your shares in Immune Pharmaceuticals Inc Worthless and that will NEVER change.
Cheers
Letterpenny
Frankel v Cytovia Therapeutics
Wrong Again no trial settlement in full case closed
CHEERS
Letterpenny very entertaining.
Perfect description for Letterpenny Letterkenny etc
Narcissists lack accountability in their actions and use blame-shifting to get the focus off themselves.
Shares revoked and will never ever trade again to say otherwise is disingenuous.
Immune pharmaceuticals of Nevada dissolved
Cheers
Letterpenny Don't worry immune pharmaceuticals will not be listed in 2023 2024 2025 2026 2027 etc
Price will always be .00000000000000000
HeHe
Cheers
PS Immune Pharmaceuticals Chapter 7 of the United States Bankruptcy Code = Total Liquidation
On April 2, 2020, the Bankruptcy Court entered an order converting the Debtor’s Chapter 11 case to Chapter 7
Letterpenny
Immune Pharmaceuticals Inc and its subsidiaries Chapter 7
Fact Immune Pharmaceuticals Chapter 7 which means total liquidation under the United States Bankruptcy Code.
You are delusional talking about Chapter 11
Total Liquidation
No new shares will be issued.
Immune pharmaceutical
shares worthless to state otherwise is disingenuous.
Cheers
Letterpenny
Immune Pharmaceuticals Inc and its subsidiaries Chapter 7
Fact Immune Pharmaceuticals Chapter 7 which means total liquidation under the United States Bankruptcy Code.
You are delusional talking about Chapter 11
Total Liquidation
No new shares will be issued.
Immune pharmaceutical
shares worthless to state otherwise is disingenuous.
Cheers
Letterpenny
Hilarious
Shares of Immune Pharmaceuticals = Zero
Cytovia Therapeutics and or Cellectis will not be coming to help Immune Pharmaceuticals shareholders.
You are delusional and or in Denial.
You do have 100% loss no doubt about it.
Cheers
Letterpenny
Hilarious
Immune Pharmaceuticals shareholders has no interest in Cellectis or Cytovia Therapeutics Inc to state otherwise is totally misleading and outright false.
Immune Pharmaceuticals Inc and its subsidiaries being liquidated.
Your shares of Immune Pharmaceuticals Worthless .
You are in denial
Have a wonderful day
Cheers
Letterpenny
Hilarious
In denial again
No new shares coming your way.
Sorry your believe but you are delusional.
Have a wonderful evening
Cheers
Letterpenny
Hilarious
Shareholders are not creditors. They own equity in a company, not debt.
Still you will be receiving Zero
Just wait and see.
HeHe
Cheers
Hilarious...
Cheers
Just look at the postings on Stocktwist and you will see that there are believers.
Sad but true.
Have a wonderful day
Cheers
Letterpenny
There's no United General or Isleworth Healthcare or Cytovia Therapeutics coming to help Immune Pharmaceuticals Inc
Immune Pharmaceuticals Inc is a company that is being Liquidated as per United States Bankruptcy Code.
The officers and directors of Immune pharmaceuticals Inc promise the shareholders everything but delivered Bankruptcy.
Cheers
Funny
Immune Pharmaceuticals of Nevada which has been dissolved.
United General LTD was only backing Immune Pharmaceuticals of Nevada and therefore is no longer in the picture.
Isleworth Healthcare also Dissolved.
You are in denial if you believe that your share will somehow become valuable.
You said you have the investment bankers accountants and advisors ask them to research immune pharmaceuticals Inc Chapter 7 liquidation.
Stated in 2017 that the board of directors and its officers had no concerns for shareholders but you thought otherwise ....
Cheers
Hilarious
Immune Pharmaceuticals of Nevada Dissolved
Immune Pharmaceuticals Inc Delaware being liquidated
Shares revoked
You are delusional if you think Immune Pharmaceuticals shares will trade.
NEVER TRADE AGAIN.
CHEERS
Unbelievable
You are delusional
Isleworth Healthcare Dissolved
Cytovia Therapeutics is a separate company and immune pharmaceuticals shareholders has absolutely no interest in Cytovia Therapeutics
Cytovia Inc is a subsidiary of Immune Pharmaceuticals and is being liquidated.
Stock registrations Revoked
Have a Great day
Cheers
Stock registration revoked.
Immune pharmaceuticals shares will never trade again.
To state otherwise is disingenuous.
Letterpenny
Hopefully this will help you to understand that there will be no Merger or Reverse merger only a corporation that will be a shell company with liabilities.
Chapter 7 bankruptcy
When a debtor becomes insolvent and the bankruptcy proceeding begins, the debtor will either liquidate its assets or reorganize its debts. The liquidation route is governed by Chapter 7 of the Bankruptcy Code.
In a liquidation, the assets of the debtor, usually a corporation, are sold in piecemeal or as a going concern “in order to satisfy the [d]ebtor[’s] creditors.” See In Re Cohen, 141 B.R. 1 (Bankr. D. Mass. 1992).
Under the Code, a trustee administers the liquidation by “marshalling all available property, reducing it to money, distributing it to creditors, and closing up the estate.” (In Re Midway Airlines, Inc., 154 B.R. 248 (N.D. Ill. 1993)). The sale of the debtor’s assets creates proceeds that are divided among interest holders in the debtor. The division of proceeds is made according to the hierarchy of the claimants’ rights.
By contrast, when an insolvent debtor is reorganized under Chapter 11, the debtor’s assets are not actually sold. Instead, the company is fictionally “sold” to existing creditors who pay for the company with their existing claims and interests. This transaction cancels the creditors' claims and interests, receiving in exchange claims against or interest in the new, reorganized entity.
Chapter 7 liquidation is the most common form of bankruptcy in the United States. The Code treats individual debtors differently from non-individuals (11 U.S. Code § 109), such as corporations, limited liabilities companies, and business partnerships. The statutory differences are explained below.
Business Entities
Business entities are eligible for Chapter 7 bankruptcy. Businesses generally file for chapter 7 liquidation when there is no possibility of achieving profitability under a chapter 11 reorganization. A chapter 7 bankruptcy terminates the company’s operations and takes the company completely out of business. A trustee assumes control of the entity to ensure that creditors benefit from the maximum value of the debtor’s assets.
The order in which creditors are paid depends on their status as creditors to the debtor. Indeed, the United States Supreme Court remarked in Czyzewski v. Jevic Holding Corp. that “[l]ower priority creditors cannot receive anything until higher priority creditors are paid in full.” Naturally, the creditor/investor who took the least amount of risk, usually a secured creditor, is paid first. A secured loan is a loan backed by collateral, meaning that if the debtor cannot repay the loan, the creditor is entitled to recover the collateral, or its cash value in lieu of the loan’s repayment. Because secured lenders know they will receive some amount of payment if the debtor declares bankruptcy, they take the least amount of risk.
Unsecured creditors have second claim to the debtor’s assets because they take greater risk than secured lenders. An unsecured creditor is a lender that does not take any security interest in the assets of the debtor, such as through collateral. Hence, when a debtor goes bankrupt, unsecured creditors may obtain only a pro rata distribution of the debtor’s assets and an amount in proportion to the size of their debt. Additionally, any recovery will come only after the secured creditors have recovered their interests.
Last in line are the company’s stockholders. They take the greatest amount of risk in the success or failure of a company. Thus, their recovery is limited by the preferential claims of secured and unsecured creditors. Stockholders cannot recover any assets if the secured and unsecured creditors’ claims are not fully repaid.
Unlike an individual debtor, a non-individual debtor does not achieve a discharge of its debts following liquidation; discharge of liability is only available to individual debtors (see 11 U.S. Code § 727). This statutory provision reflects Congress’s goal “to prevent businesses from evading liability by liquidating debtor corporations and resuming business free of debt.” In other words, corporate debt, unlike individual debt, “survives” liquidation proceedings and is “charged against the corporation when it resume[s] operations.” (N.L.R.B v. Better Bldg. Supply Corp.)
IMMUNE PHARMACEUTICALS AND ITS SUBSIDIARIES CHAPTER 7 TOTAL LIQUIDATION
Don't be delusional.
Life goes on Live and learn.
Be Well
Cheers